Cargando…
COVID-19 Testing and Diagnostics: A Review of Commercialized Technologies for Cost, Convenience and Quality of Tests
Population-scale and rapid testing for SARS-CoV-2 continues to be a priority for several parts of the world. We revisit the in vitro technology platforms for COVID-19 testing and diagnostics—molecular tests and rapid antigen tests, serology or antibody tests, and tests for the management of COVID-19...
Autores principales: | Benda, Ashler, Zerajic, Lukas, Ankita, Ankita, Cleary, Erin, Park, Yunsoo, Pandey, Santosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512798/ https://www.ncbi.nlm.nih.gov/pubmed/34640901 http://dx.doi.org/10.3390/s21196581 |
Ejemplares similares
-
Scan4CFU: Low-cost, open-source bacterial colony tracking over large areas and extended incubation times
por: Pandey, Santosh, et al.
Publicado: (2021) -
Commercial Motion Sensor Based Low-Cost and Convenient Interactive Treadmill †
por: Kim, Jonghyun, et al.
Publicado: (2015) -
A Convenient and Delicate Test for Albumen
Publicado: (1883) -
Speed and Convenience Aren't Everything with Diagnostics
Publicado: (2011) -
Evaluation of Commercially Available Serologic Diagnostic Tests for Chikungunya Virus
por: Prat, Christine M., et al.
Publicado: (2014)